Coatue Management LLC Moderna, Inc. Transaction History

Coatue Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $158 Million - $207 Million	-1,636,526 Reduced 25.0%	4,909,578 $507 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $20.7 Million - $30.1 Million	152,539 Added 2.39%	6,546,104 $1.01 Billion
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $81.3 Million - $144 Million	687,061 Added 12.04%	6,393,565 $1.15 Billion
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $20,426 - $33,593	173 Added 0.0%	5,706,504 $675 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $143 Million - $216 Million	-1,221,816 Reduced 17.64%	5,706,331 $815 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $334 Million - $621 Million	2,641,144 Added 61.61%	6,928,147 $1.19 Billion
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $398 Million - $649 Million	-1,761,923 Reduced 29.13%	4,287,003 $1.09 Billion
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $20.4 Million - $44.6 Million	-91,978 Reduced 1.5%	6,048,926 $2.33 Billion
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $634 Million - $1.15 Billion	4,883,219 Added 388.27%	6,140,904 $1.44 Billion
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $137 Million - $234 Million	1,257,685 New	1,257,685 $165 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Coatue Management LLC, based on Form 13F filings with the SEC.

Stay updated on Coatue Management LLC with notifications on news.